Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Scherma

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 25, 2020
Conditioned Place Preference (CPP) in Rats: From Conditioning to Reinstatement TestMaria Scherma, Liana Fattore, Walter Fratta, et al.
Psychiatric Genetics|August 30, 2019
Gene knockout animal models of depression, anxiety and obsessive compulsive disordersMaria Scherma, Elisa Giunti, Walter Fratta, et al.
Synapse (New York, N.Y.)|February 9, 2005
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J micePaola Fadda, Maria Scherma, Alessandra Fresu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2019
Animal Models of Eating DisordersMaria Scherma, Roberto Collu, Valentina Satta, et al.
Synapse (New York, N.Y.)|July 23, 2003
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of ratPaola Fadda, Maria Scherma, Alessandra Fresu, et al.
Frontiers in Oncology|March 25, 2025
Antibody conjugates in neuroblastoma: a step forward in precision medicineJihane Balla, Carlotta Siddi, Maria Scherma, et al.
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabinoids and their therapeutic applications in mental disorders
Maria Scherma, Anna Lisa Muntoni, Gernot Riedel, et al.
Medicines (Basel, Switzerland)|October 4, 2018
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric DisordersMaria Scherma, Paolo Masia, Matteo Deidda, et al.
International Journal of Molecular Sciences|March 6, 2021
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical ResearchPhilippe A Melas, Maria Scherma, Walter Fratta, et al.
Current Pharmaceutical Design|July 9, 2013
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidenceMaria Scherma, Liana Fattore, Maria Paola Castelli, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|September 25, 2020
Conditioned Place Preference (CPP) in Rats: From Conditioning to Reinstatement TestMaria Scherma, Liana Fattore, Walter Fratta, et al.
Psychiatric Genetics|August 30, 2019
Gene knockout animal models of depression, anxiety and obsessive compulsive disordersMaria Scherma, Elisa Giunti, Walter Fratta, et al.
Synapse (New York, N.Y.)|February 9, 2005
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J micePaola Fadda, Maria Scherma, Alessandra Fresu, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2019
Animal Models of Eating DisordersMaria Scherma, Roberto Collu, Valentina Satta, et al.
Synapse (New York, N.Y.)|July 23, 2003
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of ratPaola Fadda, Maria Scherma, Alessandra Fresu, et al.
Frontiers in Oncology|March 25, 2025
Antibody conjugates in neuroblastoma: a step forward in precision medicineJihane Balla, Carlotta Siddi, Maria Scherma, et al.
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabinoids and their therapeutic applications in mental disorders
Maria Scherma, Anna Lisa Muntoni, Gernot Riedel, et al.
Medicines (Basel, Switzerland)|October 4, 2018
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric DisordersMaria Scherma, Paolo Masia, Matteo Deidda, et al.
International Journal of Molecular Sciences|March 6, 2021
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical ResearchPhilippe A Melas, Maria Scherma, Walter Fratta, et al.
Current Pharmaceutical Design|July 9, 2013
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidenceMaria Scherma, Liana Fattore, Maria Paola Castelli, et al.
Pageof 6